Anyone with a mental health history should be closely monitored
Glutathione IV therapy is a clinic-based treatment where glutathione, an antioxidant your body naturally produces, is delivered through a vein by trained medical staff
Gastrointestinal adverse events including nausea, vomiting, and diarrhea are common with current GLP-1 agonists, leading some patients to discontinue treatment or fail to reach maximally effective doses
Semaglutide shares 94% of its sequence with human GLP-1 but has three engineered modifications: an Aib substitution at position 8 that blocks degradation by DPP-IV, an Arg at position 34, and a C18 fatty diacid attached to Lys26
Importantly, this effect often attenuates over time with long-acting agents (tachyphylaxis), though the weight loss and glycemic benefits typically persist
This dual action provides approximately 3x greater fat metabolism through the GIP pathway